JamesFrancisPingpankMD
General Surgery • Pittsburgh, PASurgical Oncology (Other than Breast)
Associate Professor, Surgery, University of Pittsburgh School of Medicine
Dr. Pingpank is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5150 Centre Ave
Pittsburgh, PA 15232Phone+1 412-692-2852Fax+1 412-647-4486
Education & Training
University of ConnecticutResidency, Surgery, 1992 - 1999
George Washington University School of Medicine and Health SciencesClass of 1992
Certifications & Licensure
PA State Medical License 1995 - 2024- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma Start of enrollment: 2009 Jun 01
Publications & Presentations
PubMed
- 2 citationsNeoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial.Diwakar Davar, Robert M Morrison, Amiran K Dzutsev, Arivarasan Karunamurthy, Joe-Marc Chauvin
Cancer Cell. 2024-11-11 - Detection of Alternative Lengthening of Telomeres via Chromogenic in situ Hybridization (ALT-CISH) for the Prognostication of PanNETs and Other Neoplasms.Christopher M Heaphy, Simmi Patel, Katelyn Smith, Anne R Wondisford, Michelle L Lynskey
Modern Pathology. 2024-11-08 - ASO Visual Abstract: Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Ca...Ahmed B Hamed, Rudy El Asmar, Nikhil Tirukkovalur, Adam Tcharni, Curtis Tatsuoka
Annals of Surgical Oncology. 2024-11-02
Journal Articles
- Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion Is Feasible and Offers Survival Benefit in Select Patients with Peritoneal MetastasesDavid L Bartlett, Filip Bednar, Reetesh K Pai, Heather L Jones, James F Pingpank, Matthew P Holtzman, Herbert J Zeh, Annals of Surgical Oncology
- Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal MalignanciesMatthew P Holtzman, James F Pingpank, David L Bartlett, Herbert J Zeh, Annals of Surgical Oncology
Press Mentions
Mesothelioma Symposium Brings Specialists and Survivors TogetherJanuary 9th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
